|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
0.000 (0.000%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 4,289,734 | 25.743% | 3,411,496 | 2,692,986 | 1,584,079 | 1,344,788 |
| Land & other Lease Assets | 366,650 | -11.576% | 414,650 | 396,862 | 327,124 | 91,516 |
| Intangible Assets | 1,270,267 | 6.018% | 1,198,163 | 772,194 | 32,625 | 0 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1,272,724 | 20.315% | 1,057,828 | 830,822 | 424,487 | 338,802 |
| 7,199,375 | 18.369% | 6,082,137 | 4,692,864 | 2,368,315 | 1,775,106 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 968,088 | -32.249% | 1,428,882 | 1,347,240 | 705,658 | 358,597 | |
| Trade Receivables | 1,005,891 | 74.856% | 575,269 | 968,405 | 475,378 | 247,854 | |
| Cash & Bank Balances | 10,052,095 | 9.705% | 9,162,823 | 8,377,095 | 7,763,833 | 4,232,642 | |
| Other Current Assets | 1,401,911 | 312.650% | 339,734 | 858,109 | 521,812 | 616,330 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 13,427,985 | 16.697% | 11,506,708 | 11,550,849 | 9,466,681 | 5,455,423 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 372,549 | 14.411% | 325,622 | 195,050 | 120,620 | 84,275 | ||
| S-T Debt & Leases | 1,220,330 | 33.458% | 914,392 | 387,273 | 271,157 | 32,550 | ||
| Other Current Liabilities | 2,883,937 | 27.654% | 2,259,184 | 2,467,724 | 1,094,074 | 926,731 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 4,476,816 | 27.938% | 3,499,198 | 3,050,047 | 1,485,851 | 1,043,556 | |||
| Net Current Assets | 8,951,169 | 11.785% | 8,007,510 | 8,500,802 | 7,980,830 | 4,411,867 | ||
| Total Assets Less Current Liabilities | 16,150,544 | 14.627% | 14,089,647 | 13,193,666 | 10,349,145 | 6,186,973 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 2,400,199 | 3.720% | 2,314,116 | 2,109,653 | 935,411 | 832,538 | |||
| Other Non-current Liabilities | 1,222,764 | 16.946% | 1,045,582 | 753,616 | 633,964 | 598,304 | |||
| 3,622,963 | 7.836% | 3,359,698 | 2,863,269 | 1,569,375 | 1,430,842 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 112 | 6.667% | 105 | 101 | 97 | 87 | ||||
| Reserves | 12,527,469 | 16.754% | 10,729,844 | 10,330,296 | 8,779,673 | 4,756,044 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 12,527,581 | 16.753% | 10,729,949 | 10,330,397 | 8,779,770 | 4,756,131 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 12,527,581 | 16.753% | 10,729,949 | 10,330,397 | 8,779,770 | 4,756,131 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 1,157,104 | -20.976% | 1,464,249 | 1,647,517 | 731,142 | 94,394 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 22/11/2024 07:32 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -392,620 |
| %Change | 182.158% |
| EPS / (LPS) | RMB -0.240 |
| NBV Per Share (¥) | RMB 7.631 |